Yearly Archives: 2023

Profile Plan, a prominent health and weight management solutions provider, has announced the offering of custom-designed nutrition plans and behavioral support to aid individuals using anti-obesity medications (AOMs), ...

Landmark Ruling by OAS Agency Rejects American Argument That the Land Claims Are Too Old and Fixing Them Would Be Too Disruptive to Non-Indigenous Settlers Living Within the Treaty Footprint ...

Ritani and HEMINCUFF Collaborate to Introduce a Luxurious Vegan Faux Crocodile Leather Lab Diamond Dog Collar, Combining Style, Sustainability, and Pet-Friendly Elegance That Is Available With Over 8 CTW of Stones ...

Professional Basketball Player Seeing More Clearly Following Treatment CINCINNATI, July 6, 2023 (Newswire.com) - ...

ROCKVILLE, Md., July 6, 2023 (Newswire.com) - The Fibroid Foundation announces the 2023 Fibroid Awareness Month July event schedule. 

The 2023 Fibroid Awareness Month Theme is "Breaking News!" All programs provide emerging insights and dynamic conversations on uterine fibroids and menstrual health. Register HERE for all programs.

Featured events are:

*July 7, 2023, at 7:00 PM EDT - Plastics and Fibroids

Featuring: 

Dr. Serdar Bulun, Chair, Department of Obstetrics and Gynecology, John J. Sciarra Professor of Obstetrics and Gynecology, Professor of Obstetrics and Gynecology and Obstetrics and Gynecology at Northwestern Medicine in Chicago, Illinois.

*July 12, 2023, at 7:00 PM EDT - Workplace Strategies for Menstrual Care

Featuring:

Milena Bacalja Perianes, Founder of HerShare, Impact Mentor at the UNICEF Venture Fund, and co-founder of Madamí.

and 

Brittany Barreto, Ph.D., Co-founder and Executive Director of FemTech Focus, Host of the FemTech Focus Podcast, and President and Founder of FemHealth Insights.

*July 19, 2023, at 7:00 PM EDT - The Black Maternal Health Crisis 

Dr. Veronica Gillispie-Bell, Obstetrician & Gynecologist, Associate Professor for Ochsner Health in New Orleans, Louisiana, Senior Site Lead and Section Head of Obstetrics and Gynecology at Ochsner Kenner and Director of Quality for Women's Services for the Ochsner Health System/Medical Director of the Minimally Invasive Center for the Treatment of Uterine Fibroids. Dr. Gillispie-Bell is also the Medical Director of the Louisiana Perinatal Quality Collaborative and Pregnancy Associated Mortality Review for the Louisiana Department of Health.

Tianna Madison, two-time Olympian, and three-time Olympic Track and Field Gold Medalist. Maternal health advocate.

*July 27, 2023, at 7:00 PM EDT - Fibroids and Menopause 

Dr. Lauren Streicher is a clinical professor of obstetrics and gynecology at Northwestern University's Feinberg School of Medicine, a Fellow in the American College of Obstetricians and Gynecologists, a member of the Sexual Medicine Society of North America, Inc., and a Top Doctor since 2002. 

Sateria Venable, Founder & CEO of The Fibroid Foundation, will moderate the panels.

Registration for all events can be found here.

The Fibroid Foundation advocates for the passage of The Stephanie Tubbs Jones Fibroid Research and Education Act - H.R. 2007 introduced in The House of Representatives by Representative Yvette D. Clarke (NY-9). The Stephanie Tubbs Jones Uterine Fibroid Research and Education Act will provide $150M to the National Institutes of Health for fibroid research. 

In the United States, an estimated 26,000,000 women between the ages of 15 and 50 have uterine fibroids.¹  Uterine fibroids are the most common gynecologic condition in women², however, treatment options and medical research funding have yet to match the enormity of the affected community. 

The "Uterine Fibroids: Burden and Unmet Medical Need" 2017 study found that, "Using ultrasound screening, the estimated cumulative incidence rate of UF (uterine fibroids) by the age of 50 is significantly higher in black women (80%) compared with white women (nearly 70%)."³ Annually, uterine fibroids account for approximately half of hysterectomies performed in the United States.  Data has shown that there are significant cardiovascular risk factors associated with hysterectomy.

According to The Fibroid Foundation, patients are suffering in silence. Community members express concerns about limited treatment options, the high cost of treatment, insurance coverage, and difficulty finding fibroid specialists. The organization recognizes the significant health disparities impacting its community and provides support to address them from a unique patient perspective. 

The Fibroid Foundation mission:

• Normalize conversations about menstruation.
• Foster a movement for everyone with a uterus to thrive.
• Eliminate treatment disparities with layered patient support.
• Engage family and community in the menstrual health mission
• Enable those diagnosed with uterine fibroids to experience a smooth path to treatment with fulfilling outcomes
• Spark joy through advocacy.
• Understand how and why fibroids develop, and ultimately find a cure.

About The Fibroid Foundation

The Fibroid Foundation is a global fibroid and menstrual health advocacy organization celebrating its 10^th Anniversary in September 2023.   

1. A systematic review of the psychosocial impact of fibroids before and after treatment

2. Epidemiology of Uterine Fibroids - From Menarche to Menopause

3. Uterine Fibroids: Burden and Unmet Medical Need

Contact Information:
Sateria Venable
Founder
info@fibroidfoundation.org
8444847698


Original Source: The Fibroid Foundation Celebrates 'Breaking News - Fibroid Awareness Month 2023'

Yachtify - the ultimate yacht marketplace. Buy and sell yachts faster than ever before with Yachtify, the most comprehensive yacht marketplace...

Sports Academy has partnered with Élevé Health, the number one global marketer and distributor of various health and wellness products, to provide athletes of all ages with the best and most efficient technologies avai...

As part of its ongoing monitoring of health-related advertising claims, the Federal Trade Commission today sent cease and desist letters – jointly with the...

Dave Chambers Dave Chambers is the new Chief Revenue Officer for Trace Minerals. OGDEN, Utah, July 5, 2023 (Newswire.com) - Trace Minerals, America's ...

A softgel consists of a gelatin-based shell surrounding a liquid or semi-solid (inner fill) drug or extract in the center. PORTLAND,...

TELF AG delves into the current state of major investments in battery materials production and the electric vehicle ecosystem in...

On Friday, June 30, 2023, the Federal Trade Commission vacated the Administrative Law Judge’s (ALJ) initial decision  in the administrative litigation challenging an alleged...